LemaA.00612.a
aspartyl-tRNA synthetase, putative
CENTER ID:
LemaA.00612.a
ORGANISM:
Leishmania major Friedlin
ASSOCIATED DISEASE:
Cutaneous leishmaniasis
CURRENT STATUS:
in PDB
COMMUNITY REQUEST:
True
NIH RISK GROUP:
2
SELECT AGENT:
False
NIH PRIORITY
pathogens category:
unclassified
Ordering Clones & Proteins
If there are materials available for this target, they will be listed below.
Materials can be ordered from SSGCID using the button in the "order material" column.
Clicking the button will add the material to a virtual cart.
You may order multiple materials at a time at no cost to you, as this contract is funded
by NIAID. When you are ready to place your order, click the "Place Order" link which will
appear in the top right corner of the page after you place your first item in your cart.
Clones*
CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO
AA
START
AA
STOP
ORDER
MATERIAL
LemaA.00612.a.B1.GE42538
full length
info
1
550
LemaA.00612.a.B1.GE42538
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis . Get sequence information
using the button in the "info" column.
Proteins
CENTER REFERENCE ID
DOMAIN/REGION DESCRIPTION
INFO
AA START
AA STOP
ORDER MATERIAL
LemaA.00612.a.B1.PW38547
full length
info
1
550
PW38547
Structures
6OD8
DEPOSITED: 3/26/2019
DETERMINATION: XRay
CLONE: LemaA.00612.a.B1.GE42538
PROTEIN: LemaA.00612.a.B1.PW38547
Sequences
These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols.
To find the specific sequence of any material you may have ordered, click on the "info" button next to the name of that material.
AA Sequence
MSANHADAGA PAVAKKMSDK EARKAARLAE EKARADEKAA LVEKYKAVFG AAPMVQSTTY KSRTHIPVSE LSRPELVDKT VLIRARVSTT RKKGKMAFMV LRDGSDSVQA MAAVEGDVPK EMIDFMGQIA TESIVDVEAT VCKVEQPITS TSHSDIELKV KKIHTVTESL RTLPFTLEDA SRKESAEGAK VNLDTRLNSR WMDLRTLASG AIFRLQSRVC QYFRQFLIDK DFCEIHSPKI INAPSEGGAN VFKLEYFNRF AYLAQSPQLY KQMVLQGDVP RVFEVGPVFR SENSNTHRHL TEFVGLDVEM RIDEHYYEVL DVAESLFNYI FERLATHTKE LKNVCQQYPF EPLVWKLTPE RIKELGVGVI SEGVVPTDKF QARVHNMDSR MLRINYMHCI ELLNTVLDEK MAPTDDINTT NEKLLGKLVK ERYGTDFFIS DRFPSSARPF YTMECKDDVR FTNSYDMFIR GEEISSGAQR IHDPDLLLAR AKMLNVDLTP IKEYVDSFRL GAWPHGGFGI GLERVVMLYL GLSNVRLASL FPRDPQRTTP
NT Sequence
atgagcgcaa accacgccga tgccggcgca ccagccgtgg cgaagaagat gagcgacaaa gaggcgcgta aggcggcgcg cctggcggag gagaaggccc gcgcggatga aaaggcggcc cttgtggaga agtacaaggc cgtgtttggt gccgcaccaa tggtgcagtc gacgacgtac aagtcgcgca cgcacatccc ggtctcggag ctgtcgcggc cggagttggt ggacaagacg gtgctgatcc gtgcccgcgt gtcgacgacg cgcaagaagg gcaagatggc gttcatggtg ctgcgcgacg ggagcgattc ggtgcaggcg atggctgccg tggaaggcga tgtgccgaag gagatgatcg acttcatggg gcagatcgcg acagagtcga ttgttgatgt ggaggcgaca gtttgcaagg tggagcagcc catcacgtcg acgtcgcact cggacatcga gctgaaggtg aagaagatcc acacggtgac ggagtcgctg cgcacgctgc cgttcacgct agaggacgcg agccgcaagg agtcggccga gggtgcgaag gtgaacctcg acacgcgcct gaatagccgc tggatggacc tgcgcacact agcgtccggc gcgatcttcc gccttcagtc gcgcgtgtgc cagtacttcc gccagtttct tatcgacaag gacttctgtg agatccactc gcccaagatc atcaacgcgc cgagcgaggg tggcgccaac gtgttcaagc tggagtactt caaccgcttc gcgtaccttg cccagtcgcc acaactgtac aagcagatgg tgctgcaggg cgatgtgccg cgcgtgttcg aggtgggacc ggtgttccgc tcagagaaca gcaacacaca ccgccacctg acggagtttg ttgggttgga cgtggagatg cgcatcgatg agcactacta cgaggtgctg gatgtggcgg agagcctatt caactacatt ttcgagcgcc ttgccactca cacaaaggag ctgaagaacg tgtgccagca gtaccccttc gagcctctcg tgtggaagct cacaccggag aggataaagg agctcggcgt tggcgtcatc tcggagggcg tggtgccgac agacaagttt caggcacgcg tgcacaacat ggatagccgt atgctgcgta tcaactacat gcactgcatt gagctgttga acactgtgct ggacgagaag atggcgccga cggatgacat caacacgacg aacgagaagc tgctcggcaa gcttgtgaag gagcgctacg gcacagactt cttcatctcg gaccgctttc cgtcctcggc gcgcccgttc tacacgatgg agtgcaagga cgacgtgcgc ttcacgaact cgtacgatat gttcatccgc ggtgaggaga tctccagcgg agcgcagcgc atccacgacc ccgatctgct gctggcacgc gccaagatgc tgaacgtgga tctcacaccg atcaaggagt acgtcgactc cttccgtctc ggtgcgtggc cgcacggcgg cttcggcatt gggctggagc gcgtggtgat gctgtacctt ggactgagca acgtgcgcct tgcttcgctc tttccgcgtg acccgcagcg cacgacgcca tag
Details for LemaA.00612.a.B1.GE42538
HARVESTED ON:
7/3/2018
SEQUENCED ON:
7/10/2018
EXPECTED MW:
63kDa
OBSERVED MW:
63kDa
ANTIBIOTIC MARKER:
ampicillin
COUNT OF EXPRESSION COLONIES:
Good (10-50)
TOTAL EXPRESSION LEVEL:
Moderate Expression
SOLUBLE EXPRESSION LEVEL
Moderate Expression
EXPRESSION HOST:
BL 21 (DE3) Rosetta
SEQUENCING RESULT:
PERCENT IDENTITY:
96
PERCENT COVERAGE:
98
Details for LemaA.00612.a.B1.PW38547
PURIFICATION DATe:
10/15/2018
CONCENTRATION:
43.59mg/ml
OBSERVED MW:
63kDa
EXPRESSION LEVEL:
Moderate Expression
PROTEIN PURIFICATION BUFFER:
25 mM HEPES pH 8, 500 mM NaCl, 5% Glycerol , 2 mM DTT, 0.025% Azide, 1mM ATP
EXPRESSION HOST:
BL 21 (DE3) Rosetta
VIAL COUNT (approx.):
4
VIAL VOLUME:
210µl
PERCENT IDENTITY:
96
PERCENT COVERAGE:
98